Secondary colonic stent insertion in acute large bowel obstruction following primary stent failure.


Journal

Annals of the Royal College of Surgeons of England
ISSN: 1478-7083
Titre abrégé: Ann R Coll Surg Engl
Pays: England
ID NLM: 7506860

Informations de publication

Date de publication:
Feb 2020
Historique:
pubmed: 30 10 2019
medline: 18 2 2020
entrez: 30 10 2019
Statut: ppublish

Résumé

Colonic stent insertion has been shown to be an effective treatment for patients with acute large bowel obstruction, either as a bridge to surgery or as definitive treatment. However, little is known of the role of secondary stent insertion following primary stent failure in patients considered inappropriate or high risk for emergency surgery. Fourteen patients presenting with acute large bowel obstruction who had previously been treated with colonic stent insertion were studied. All underwent attempted placement of a secondary stent. Technical deployment of the stent was accomplished in 12 patients (86%) but only 9 (64%) achieved clinical decompression. Successful deployment and clinical decompression of a secondary stent was associated with older age ( Secondary colonic stent insertion appears an effective, safe treatment in the majority of patients presenting with acute large bowel obstruction following failure of a primary stent.

Identifiants

pubmed: 31660754
doi: 10.1308/rcsann.2019.0136
pmc: PMC6996421
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-143

Références

Lancet Oncol. 2011 Apr;12(4):344-52
pubmed: 21398178
Br J Surg. 2007 Dec;94(12):1451-60
pubmed: 17968980
Dis Colon Rectum. 2015 Mar;58(3):358-62
pubmed: 25664716
Br J Surg. 2012 Apr;99(4):469-76
pubmed: 22261931
Surg Endosc. 2013 Sep;27(9):3288-96
pubmed: 23519493
Gastrointest Endosc. 2011 Oct;74(4):858-68
pubmed: 21862005
Colorectal Dis. 2003 Sep;5(5):518-21
pubmed: 12925093
Colorectal Dis. 2014 Jun;16(6):476-83
pubmed: 24506142
J Gastrointest Surg. 2014 Mar;18(3):584-91
pubmed: 24170606
Gastrointest Endosc. 2011 Sep;74(3):625-33
pubmed: 21762906

Auteurs

A Lazzaro (A)

Royal Free London NHS Foundation Trust, UK.

A Saini (A)

Royal Free London NHS Foundation Trust, UK.

C Elton (C)

Royal Free London NHS Foundation Trust, UK.

G K Atkin (GK)

Royal Free London NHS Foundation Trust, UK.

I C Mitchell (IC)

Royal Free London NHS Foundation Trust, UK.

K Lotzof (K)

Royal Free London NHS Foundation Trust, UK.

A Marcus (A)

Royal Free London NHS Foundation Trust, UK.

P Mathur (P)

Royal Free London NHS Foundation Trust, UK.

D J Boyle (DJ)

Royal Free London NHS Foundation Trust, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH